These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5172424)

  • 21. [Long term results in the 300 most grave cases out of 4000 hyperthyroid patients treated with iodine I-131 at the center of Ancona].
    Gennarelli L; Lenti R
    Minerva Med; 1965 Aug; 56(65):2635-6. PubMed ID: 5896860
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The late incidence of hypothyroidism after therapy of hyperthyroidism with radioiodine.
    Spring M
    J Nucl Med; 1967 May; 8(5):399. PubMed ID: 6071817
    [No Abstract]   [Full Text] [Related]  

  • 24. Delay in control of 131-I-treated thyrotoxicosis is avoidable.
    Hamburger JI; Kadian G; Rossin HW
    J Clin Endocrinol Metab; 1968 May; 28(5):721-4. PubMed ID: 5694721
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in the absorptive-excretory function of the liver, determined by the rose-bengal-I-131 test in patients with thyrotoxicosis undergoing radioiodine therapy].
    Belosludtsev IA; Trusov VV
    Probl Endokrinol Gormonoter; 1965; 11(6):36-9. PubMed ID: 5874644
    [No Abstract]   [Full Text] [Related]  

  • 26. [Radioactive iodine treatment of patients with relapsing toxic goiter].
    Iaroslavtsev SA
    Klin Med (Mosk); 1968 Sep; 46(9):106-10. PubMed ID: 5756042
    [No Abstract]   [Full Text] [Related]  

  • 27. [The sialic acid content of the blood of thyrotoxicosis patients treated with radioiodine].
    Udod VM; Kuz'mak NI
    Med Radiol (Mosk); 1967 Apr; 12(4):45-8. PubMed ID: 6052183
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of thyrostatic preparations to reduce the radioresistance of toxic goiter during radioiodine treatment].
    Livergant IuE; Suslina NG
    Med Radiol (Mosk); 1968 Jul; 13(7):9-11. PubMed ID: 4190228
    [No Abstract]   [Full Text] [Related]  

  • 29. Fractionated 131-I therapy in large toxic goitres.
    Säterborg NE; Einhorn J
    Acta Endocrinol (Copenh); 1966 Jan; 51(1):7-14. PubMed ID: 5951910
    [No Abstract]   [Full Text] [Related]  

  • 30. [Criteria for the fractional radioiodine therapy of hyperthyroidism].
    Reinwein D; Klein E; Horster FA; Gabe D
    Verh Dtsch Ges Inn Med; 1967; 73():372-5. PubMed ID: 5591779
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in the hemodynamics of patients with toxic goiter following treatment with radioactive iodine (according to radiocardiographic findings)].
    Katsevman AE
    Med Radiol (Mosk); 1971 Nov; 16(11):36-40. PubMed ID: 4950000
    [No Abstract]   [Full Text] [Related]  

  • 32. [Functional condition of the liver in patients with diffuse toxic goiter before and after treatment by I-131].
    Siesivieva VG; Shlevkov BA; Belousova ND
    Med Radiol (Mosk); 1966 May; 11(5):21-7. PubMed ID: 6014327
    [No Abstract]   [Full Text] [Related]  

  • 33. [Megakaryocytopoiesis and thrombocytopoiesis in patients with diffuse toxic goiter during the period of treatment with I-131].
    Piksanov ON; Bykhovskaia AM
    Med Radiol (Mosk); 1967 Jan; 12(1):82-5. PubMed ID: 5633100
    [No Abstract]   [Full Text] [Related]  

  • 34. [POTASSIUM, SODIUM AND CALCIUM CONTENT IN THE BLOOD SERUM IN THYROTOXICOSIS PATIENTS BEFORE AND AFTER RADIOIODINE (I-131) THERAPY].
    SPESIVTSEVA VG; KHANMAMEDOVA IV
    Ter Arkh; 1964 Oct; 36():117-22. PubMed ID: 14309907
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dynamics of some indices of the glucocorticoid function of the adrenal cortex in patients with a severe form of diffuse toxic goiter under the effect of radioiodine treatment].
    Lipets AI; Dozorets IuL; Seleznev LE
    Sov Med; 1971 Sep; 34(9):63-5. PubMed ID: 5171297
    [No Abstract]   [Full Text] [Related]  

  • 36. Decreased post-heparin lipases in Graves's disease.
    Arons DL; Schreibman PH; Downs P; Braverman LE; Arky RA
    N Engl J Med; 1972 Feb; 286(5):233-7. PubMed ID: 5066600
    [No Abstract]   [Full Text] [Related]  

  • 37. [Menstrual and reproductive function after radioiodine therapy for thyrotoxicosis].
    Vorozhba NV; Filatova TP
    Med Radiol (Mosk); 1969 Dec; 14(12):20-3. PubMed ID: 5381851
    [No Abstract]   [Full Text] [Related]  

  • 38. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
    Hoeschel M; Heinze HG
    Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Remote results of the treatment of patients with toxic goiter by radioactive iodine (I-131)].
    Petrova MM; Kurbatova LI
    Probl Endokrinol Gormonoter; 1965; 11(3):52-6. PubMed ID: 5898801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.